Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Metformin × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 7 Obesity 2 Endometrial Hyperplasia 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Metformin 1 Metabolic Diseases 1 Ketosis 1 Insulin Resistance 1 Infertility 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Diabetes, Gestational 1 Communicable Diseases 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03618472 2024-12-03

Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells

Department of Medical Services Ministry of Public Health of Thailand

Phase NA Completed

Metformin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡